Log in
CVE:NRM

Noram Ventures Stock Forecast, Price & News

C$0.16
+0.01 (+3.33 %)
(As of 10/23/2020 12:36 PM ET)
Add
Compare
Today's Range
C$0.16
Now: C$0.16
C$0.16
50-Day Range
C$0.15
MA: C$0.18
C$0.20
52-Week Range
C$0.05
Now: C$0.16
C$0.27
Volume41,000 shs
Average Volume199,505 shs
Market CapitalizationC$7.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Noram Ventures Inc., a junior exploration company, engages in the acquisition, exploration, and development of mineral properties. It explores for lithium and graphite deposits. The company's flagship property is the Zeus Lithium property located in Clayton Valley, Nevada. Noram Ventures Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars

Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-778-7751528
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC$0.07 per share

Profitability

Miscellaneous

Market CapC$7.58 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.16
+0.01 (+3.33 %)
(As of 10/23/2020 12:36 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NRM News and Ratings via Email

Sign-up to receive the latest news and ratings for NRM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Noram Ventures (CVE:NRM) Frequently Asked Questions

How has Noram Ventures' stock price been impacted by COVID-19?

Noram Ventures' stock was trading at C$0.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NRM shares have increased by 19.2% and is now trading at C$0.16.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Noram Ventures?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Noram Ventures in the last year. There are currently 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy."
View analyst ratings for Noram Ventures
.

What price target have analysts set for NRM?

1 brokers have issued 12 month price targets for Noram Ventures' stock. Their forecasts range from C$0.40 to C$0.40. On average, they anticipate Noram Ventures' stock price to reach C$0.40 in the next year. This suggests a possible upside of 158.1% from the stock's current price.
View analysts' price targets for Noram Ventures
.

Who are some of Noram Ventures' key competitors?

What other stocks do shareholders of Noram Ventures own?

Who are Noram Ventures' key executives?

Noram Ventures' management team includes the following people:
  • C. Tucker Barrie Ph.D., CEO & Pres
  • Ms. Anita Young Algie, Chief Financial Officer (Age 37)
  • Mr. Greg Lytle, Communications Mang.

What is Noram Ventures' stock symbol?

Noram Ventures trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NRM."

How do I buy shares of Noram Ventures?

Shares of NRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Noram Ventures' stock price today?

One share of NRM stock can currently be purchased for approximately C$0.16.

How big of a company is Noram Ventures?

Noram Ventures has a market capitalization of C$7.58 million.

What is Noram Ventures' official website?

The official website for Noram Ventures is www.noramventures.com.

How can I contact Noram Ventures?

Noram Ventures' mailing address is 430-580 Hornby St, VANCOUVER, BC V6C 3B6, Canada. The company can be reached via phone at +1-778-7751528.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.